Histone Deacetylation
Products Related to Histone Deacetylation(43)
- GC11641Boc-Lys(Ac)-AMCCAS: 233691-67-3Purity: >99.00%
Boc-Lys(Ac)-AMC is a substrate of histone deacetylases (HDACs).
- GC18915Trapoxin ACAS: 133155-89-2Purity: >98%
Trapoxin A is a cyclotetrapeptide histone deacetylase (HDAC) inhibitor.
- GC19936Quisinostat dihydrochlorideCAS: 875320-31-3Purity: >98%
Quisinostat dihydrochloride (JNJ-26481585 dihydrochloride) is an orally available, potent pan-HDAC inhibitor with IC50s of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM, and 0.37 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11, respectively. Quisinostat dihydrochloride has a broad spectrum antitumoral activity.
- GC41495HDAC3 InhibitorCAS: 2044701-99-5Purity: >98.00%
HDAC3 Inhibitor (compound 5) is a potent and selective HDAC3 inhibitor, with an IC50 of 5.96 nM.
- GC43318coumarin-SAHACAS: 1260635-77-5Purity: >98.00%
Suberoylanilide hydroxamic acid (SAHA) is a class I and class II histone deacetylase (HDAC) inhibitor that binds directly to the catalytic site of the enzyme thereby blocking substrate access.
- GC44865SAHA-BPyneCAS: 930772-88-6Purity: >98.00%
Suberoylanilide hydroxamic acid (SAHA) is a class I and class II histone deacetylase (HDAC) inhibitor that binds directly to the catalytic site of the enzyme thereby blocking substrate access.
- GC45080Trichostatin CCAS: 68676-88-0Purity: >95.00%
Trichostatin C is a glycosylated derivative of trichostatin A, the antifungal antibiotic that reversibly inhibits histone deacetylase.
- GC45095Tubastatin A (trifluoroacetate salt)CAS: 1239262-52-2Purity: >95.00%
Tubastatin A is a potent HDAC6 inhibitor with an IC50 value of 15 nM.
- GC45137Valproic Acid Acyl-D-GlucuronidePurity: >95.00%
Valproic acid acyl-D-glucuronide is the major urinary metabolite of valproic acid.
- GC46104Butyric Acid-d7CAS: 73607-83-7Purity: >98.00%
An internal standard for the quantification of sodium butyrate
- GC466284-Chloro-6,7-bis(2-methoxyethoxy)quinazolineCAS: 183322-18-1Purity: >95.00%
A building block and synthetic intermediate
- GC46892ATRA-BA HybridCAS: 1037543-26-2Purity: >95.00%
A prodrug form of all-trans retinoic acid and butyric acid
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC11641 | Boc-Lys(Ac)-AMC | 233691-67-3 | >99.00% | |
Boc-Lys(Ac)-AMC is a substrate of histone deacetylases (HDACs). | ||||
| GC18408 | BML-278 | 120533-76-8 | >98% | |
BML-278 is an activator of sirtuin 1 (SIRT1) that has an EC150 value (effective concentration able to increase the enzyme by 150%) of 1 uM. | ||||
| GC18915 | Trapoxin A | 133155-89-2 | >98% | |
Trapoxin A is a cyclotetrapeptide histone deacetylase (HDAC) inhibitor. | ||||
| GC19384 | WT-161 | 1206731-57-8 | - | |
WT-161 is a potent and selective HDAC6 inhibitor with an IC50 of 0.40 nM. | ||||
| GC19936 | Quisinostat dihydrochloride | 875320-31-3 | >98% | |
Quisinostat dihydrochloride (JNJ-26481585 dihydrochloride) is an orally available, potent pan-HDAC inhibitor with IC50s of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM, and 0.37 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11, respectively. Quisinostat dihydrochloride has a broad spectrum antitumoral activity. | ||||
| GC39551 | BRD3308 | 1550053-02-5 | >98.00% | |
BRD3308 is a highly selective HDAC3 inhibitor with an IC50 of 54 nM. | ||||
| GC40674 | APHA Compound 8 | 676599-90-9 | >98.00% | |
A class I and II HDAC inhibitor | ||||
| GC40923 | BRD4884 | 1404559-91-6 | >98.00% | |
BRD4884 is an HDAC inhibitor with IC50 values of 29 nM, 62 nM, and 1.09 μM for HDAC1, 2, and 3, respectively. | ||||
| GC41495 | HDAC3 Inhibitor | 2044701-99-5 | >98.00% | |
HDAC3 Inhibitor (compound 5) is a potent and selective HDAC3 inhibitor, with an IC50 of 5.96 nM. | ||||
| GC41601 | CAY10591 | 839699-72-8 | >98.00% | |
CAY10591 is a potent activator of Sirt1 and suppresses TNF-α in a dose-dependent manner. | ||||
| GC43147 | CAY10398 | 193551-00-7 | >98.00% | |
CAY10398 is an inhibitor of histone deacetylase (HDAC1) with an IC50 value of 10 μM. | ||||
| GC43201 | CAY10722 | 388086-13-3 | >98.00% | |
CAY10722 is an inhibitor of sirtuin 3 (SIRT3), a class III HDAC (71% inhibition at 200 μM). | ||||
| GC43318 | coumarin-SAHA | 1260635-77-5 | >98.00% | |
Suberoylanilide hydroxamic acid (SAHA) is a class I and class II histone deacetylase (HDAC) inhibitor that binds directly to the catalytic site of the enzyme thereby blocking substrate access. | ||||
| GC43806 | HC Toxin | 83209-65-8 | >98.00% | |
HC Toxin is a cell-permeable, reversible inhibitor of histone deacetylases (HDACs) (IC50 = 30 nM). | ||||
| GC44865 | SAHA-BPyne | 930772-88-6 | >98.00% | |
Suberoylanilide hydroxamic acid (SAHA) is a class I and class II histone deacetylase (HDAC) inhibitor that binds directly to the catalytic site of the enzyme thereby blocking substrate access. | ||||
| GC44866 | SAHA-d5 | 1132749-48-4 | >99.00% | |
SAHA-d5 (SAHA-d5) is the deuterium labeled Vorinostat. | ||||
| GC45080 | Trichostatin C | 68676-88-0 | >95.00% | |
Trichostatin C is a glycosylated derivative of trichostatin A, the antifungal antibiotic that reversibly inhibits histone deacetylase. | ||||
| GC45095 | Tubastatin A (trifluoroacetate salt) | 1239262-52-2 | >95.00% | |
Tubastatin A is a potent HDAC6 inhibitor with an IC50 value of 15 nM. | ||||
| GC45137 | Valproic Acid Acyl-D-Glucuronide | - | >95.00% | |
Valproic acid acyl-D-glucuronide is the major urinary metabolite of valproic acid. | ||||
| GC46104 | Butyric Acid-d7 | 73607-83-7 | >98.00% | |
An internal standard for the quantification of sodium butyrate | ||||
| GC46226 | SS-208 | 2245942-72-5 | >98.00% | |
An HDAC6 inhibitor | ||||
| GC46628 | 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline | 183322-18-1 | >95.00% | |
A building block and synthetic intermediate | ||||
| GC46736 | 7-Bromoheptanoic Acid | 30515-28-7 | >95.00% | |
A building block | ||||
| GC46892 | ATRA-BA Hybrid | 1037543-26-2 | >95.00% | |
A prodrug form of all-trans retinoic acid and butyric acid | ||||
